The introducing India first skin microbiome test marks a major step forward in personalized skincare as Leucine Rich Bio Pvt. Ltd., South Asia’s leading microbiome company, unveils its latest innovation, the BugSpeaks Facial Skin Microbiome Test. Launched on October 6, 2023, this groundbreaking test is the first of its kind in the region. And promises to transform how people understand and care for their skin.
Our skin is home to millions of tiny microbes, invisible helpers that protect us from germs, heal wounds, and support the immune system. However, these good microbes can lose balance due to pollution, hormonal changes, or harsh skincare products. When that happens, the skin becomes more prone to irritation, acne, and dryness. The BugSpeaks test aims to restore this balance by analyzing an individual’s skin microbiome and offering tailored skincare recommendations.
The BugSpeaks facial test studies the microorganisms that live on the skin’s surface and provides a detailed overview of skin health. It measures important factors such as hydration, elasticity, and barrier strength, helping users understand how their skin functions. The test follows a four-step scientific process:
- Quality control
- DNA sequencing
- Data analysis
- Report verification
After completing the test, users receive a personalized report that includes insights on skincare ingredients, dietary advice, and probiotic suggestions. The recommendations are designed around an individual’s lifestyle, work environment, diet, and genetics, ensuring a holistic approach to skin health.
Globally, the skin microbiome market is expanding rapidly. Valued at around USD 1.03 billion in 2024, it is projected to nearly triple by 2032. Moreover, his growth reflects the rising demand for science-based, customized skincare solutions, particularly in regions like the Middle East and the Gulf Cooperation Council (GCC).
Leucine Rich Bio has built its reputation on high-quality research and trusted practices. The company holds ISO 9001:2015 and ISO/IEC 17025 certifications, ensuring world-class laboratory standards. So, the BugSpeaks facial test follows their successful BugSpeaks Gut Microbiome Test, launched in 2017, South Asia’s first gut microbiome analysis.
Co-Founder and Director Dr. Debojyoti Dhar explained the motivation behind this innovation: “We took time to design a skin test that offers actionable results. Our goal is to use microbiome science to improve people’s skin health and overall well-being.” His focus on combining scientific research with practical skincare solutions underscores the test’s purpose.
Kumar Sankaran, CEO of Leucine Rich Bio, added, “The BugSpeaks skin microbiome test can revolutionize skin healthcare. It will also raise awareness about the vital role of microbes in our well-being.” In addition, the company plans to partner with dermatologists, beauty experts, and wellness centers to make microbiome-based skincare a mainstream practice.
However, the test also supports preventive healthcare. Identifying early signs of skin imbalance can help users adopt better habits and prevent potential problems. This approach aligns with the growing trend of using scientific diagnostics to maintain overall health.
Founded in 2014, Leucine Rich Bio has been a pioneer in microbiome science in South Asia. Their mission is to bridge the gap between research and daily health through personalized, data-driven solutions. With the launch of the new skin microbiome test, the company continues its mission to make people aware of how microbes influence beauty and health.
In conclusion, the introducing India first skin microbiome test reflects a new era in skincare, one powered by science, technology, and personalization. As this innovation reaches more people, it may redefine how individuals care for their skin. And focusing not just on appearance but also on long-term health and balance.
